NCI-H647 Cells

NCI-H647 cells are a human lung carcinoma cell line derived from a patient with large cell carcinoma of the lung. This cell line is part of the NCI (National Cancer Institute) panel of human tumor cell lines used extensively in cancer research, particularly in studies concerning lung cancer biology and therapeutics. The NCI-H647 cell line exhibits characteristics typical of large cell lung carcinoma, including rapid growth and the ability to form tumors when xenografted into immunocompromised mice. These cells are particularly useful for exploring the molecular mechanisms of lung cancer pathogenesis, including signal transduction pathways, genetic mutations involved in cancer progression, and the role of tumor microenvironment factors. NCI-H647 cells are often employed in drug screening studies to evaluate the efficacy and toxicity of chemotherapeutic agents and targeted therapies. Their responsiveness to various anti-cancer compounds helps in understanding the pharmacodynamics and potential resistance mechanisms of lung cancer treatments. This cell line is also used to study the interaction between cancer cells and therapeutic agents, providing insights into the development of more effective and personalized treatment strategies for lung cancer patients. Overall, the NCI-H647 cell line serves as a critical tool in lung cancer research, facilitating advancements in understanding the disease and developing novel therapeutic approaches. Lung cancer cell lines, Lung, Lung adenosquamous carcinoma, Growth Conditions: Adherent, Biosafety level: BSL 1